185 related articles for article (PubMed ID: 32532560)
1. [Update on beta blockers in 2020].
Bejan-Angoulvant T; Angoulvant D
Rev Med Interne; 2020 Nov; 41(11):741-747. PubMed ID: 32532560
[TBL] [Abstract][Full Text] [Related]
2. Role of beta-blockers in patients with COPD: current perspective.
Malerba M; Montuschi P; Radaeli A; Pirisi M
Drug Discov Today; 2015 Jan; 20(1):129-35. PubMed ID: 25238736
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.
Petta V; Perlikos F; Loukides S; Bakakos P; Chalkias A; Iacovidou N; Xanthos T; Tsekoura D; Hillas G
Heart Fail Rev; 2017 Nov; 22(6):753-763. PubMed ID: 28840400
[TBL] [Abstract][Full Text] [Related]
4. Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
Gelosa P; Castiglioni L; Camera M; Sironi L
Biochem Pharmacol; 2020 Jul; 177():113895. PubMed ID: 32145263
[TBL] [Abstract][Full Text] [Related]
5. β-Blockers and chronic obstructive pulmonary disease: inappropriate avoidance?
Minor DS; Meyer AM; Long RC; Butler KR
J Clin Hypertens (Greenwich); 2013 Dec; 15(12):925-30. PubMed ID: 24102872
[TBL] [Abstract][Full Text] [Related]
6. Clinical inquiries. Do beta-blockers worsen respiratory status for patients with COPD?
Baselli LM; Oswald MA; Nashelsky JM
J Fam Pract; 2005 May; 54(5):472-3. PubMed ID: 15865911
[No Abstract] [Full Text] [Related]
7. Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
Mtisi TF; Frishman WH
Cardiol Rev; 2020; 28(1):20-25. PubMed ID: 31804289
[TBL] [Abstract][Full Text] [Related]
8. [How to properly use beta-blockers ?].
Lopes D; Sartori C
Rev Med Suisse; 2018 Nov; 14(628):2097-2101. PubMed ID: 30462396
[TBL] [Abstract][Full Text] [Related]
9. β-Blockers, heart disease and COPD: current controversies and uncertainties.
Baker JG; Wilcox RG
Thorax; 2017 Mar; 72(3):271-276. PubMed ID: 27927840
[TBL] [Abstract][Full Text] [Related]
10. [The present status and prospects of therapeutic use of beta-blockers in diseases of the cardiovascular system].
Kuzelová M; Svec P
Ceska Slov Farm; 1998 Feb; 47(1):4-9. PubMed ID: 9600149
[TBL] [Abstract][Full Text] [Related]
11. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
[TBL] [Abstract][Full Text] [Related]
12. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
Rutten FH
Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
[TBL] [Abstract][Full Text] [Related]
13. [Beta blockers and cardiovascular risk in chronic obstructive pulmonary disease].
Machado-Alba JE; Medina-Morales DA; Bañol-Giraldo AM; Machado-Duque ME
Rev Med Chil; 2014 Jun; 142(6):807-8. PubMed ID: 25327330
[No Abstract] [Full Text] [Related]
14. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
Mersfelder TL; Shiltz DL
Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
[No Abstract] [Full Text] [Related]
15. [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].
Pescaru C; Tudorache V; Oancea C
Pneumologia; 2010; 59(1):27-30. PubMed ID: 20432790
[TBL] [Abstract][Full Text] [Related]
16. Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.
Egred M; Shaw S; Mohammad B; Waitt P; Rodrigues E
QJM; 2005 Jul; 98(7):493-7. PubMed ID: 15955798
[TBL] [Abstract][Full Text] [Related]
17. Beta-blocker under-use in COPD patients.
Lim KP; Loughrey S; Musk M; Lavender M; Wrobel JP
Int J Chron Obstruct Pulmon Dis; 2017; 12():3041-3046. PubMed ID: 29089752
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
Matera MG; Martuscelli E; Cazzola M
Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S
JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680
[TBL] [Abstract][Full Text] [Related]
20. [Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
Bułdak Ł; Duława A; Krysiak R; Okopień B
Pol Merkur Lekarski; 2008 Feb; 24(140):121-4. PubMed ID: 18637263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
